Page last updated: 2024-12-05

dimazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dimazine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,1-dimethylhydrazine : A member of the class of hydrazines that is hydrazine substituted by two methyl groups at position 1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5976
CHEBI ID18853
MeSH IDM0062143

Synonyms (77)

Synonym
1,1-dimethyl-hydrazine
hydrazine, 1,1-dimethyl-
1,1-dimethyl hydrazine
dimethylhydrazine, as
dimazine
nsc-60517
hydrazine,n-dimethyl-
57-14-7
1,1-dimethylhydrazine
hydrazine,1-dimethyl-
wln: zn1&1
nsc60517
n,n-dimethylhydrazine
udmh
1,1-dimethylhydrazin
dimazin
as-dimethylhydrazine
c2h8n2
gem-dimethylhydrazine
rcra waste no. u098
unsymmetrical dimethylhydrazine
u-dimethylhydrazine
ccris 258
n,n-dimetilidrazina [italian]
unsymmetrical-dimethylhydrazine
niesymetryczna dwu metylohydrazyna [polish]
nsc 60517
asymmetric-dimethylhydrazine
as-dimethyl hydrazine
unsym-dimethylhydrazine
brn 0605261
asymmetric dimethylhydrazine
1,1-dimethylhydrazin [german]
uns-dimethylhydrazine
einecs 200-316-0
hydrazine, n,n-dimethyl-
hsdb 528
dimethylhydrazine unsymmetrical
un1163
rcra waste number u098
n,n-dimethylhydrazine, 98%
dimethyl hydrazine (dmh)
inchi=1/c2h8n2/c1-4(2)3/h3h2,1-2h
CHEBI:18853
AKOS000119664
1,1-dimethyldiazane
A831327
C19233
cas-57-14-7
dtxsid1020516 ,
tox21_302358
dtxcid50516
NCGC00255194-01
D0740
dimethylhydrazine, unsym.
niesymetryczna dwu metylohydrazyna
dimethylhydrazine, unsymmetrical
dimethylhydrazine, unsymmetrical [un1163] [poison]
n,n-dimetilidrazina
unii-4wpq90n53j
4wpq90n53j ,
ec 200-316-0
1,1-dimethylhydrazine [mi]
1,1-dimethylhydrazine [iarc]
1,1-dimethylhydrazine [hsdb]
un 1163
me2nnh2
asym-dimethylhydrazine
unsymmetrical-dimethylhyrazine
(ch3)2nnh2
n,n-dimethyl-hydrazine
n,n-dimethyl hydrazine
n',n'-dimethylhydrazine
Q-200052
Q161296
mfcd00007628
1.1-dimethylhydrazine

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" The aim of the present study was to assess the carcinogenicity of daminozide alone and in combination with 1,1-dimethylhydrazine (UDMH), its major contaminant, in a novel medium-term bioassay in Fischer 344 rats, the DEN-PH model."( Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
Cabral, R; Hakoi, K; Hasegawa, R; Hoshiya, T; Ito, N,
)
0.13

Dosage Studied

ExcerptRelevanceReference
" The highest frequency of micronuclei and dose-response relationship between PGE2 doses and micronucleus frequency were observed 30 h after injection of MMC to mice administered PGE2 24 h previously."( Effects of prostaglandin E2 on the micronucleus formation in mouse bone marrow cells by various mutagens.
Fukumoto, M; Ishikawa, T; Kadokura, M; Okonogi, H; Sakaba, H; Shimizu, H; Suzuki, Y, 1994
)
0.29
" This study suggests that UDMH administered at the above dosage was not carcinogenic in this model."( Unsymmetrical DMH - an isomer of 1,2 DMH - is it potent to induce gastrointestinal carcinoma in rats?
Christudoss, P; Fleming, JJ; Mathew, G; Pulimood, AB; Selvakumar, R, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
teratogenic agentA role played by a chemical compound in biological systems with adverse consequences in embryo developments, leading to birth defects, embryo death or altered development, growth retardation and functional defect.
fuelAn energy-rich substance that can be transformed with release of usable energy.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydrazinesHydrazine (diazane) and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (81)

TimeframeStudies, This Drug (%)All Drugs %
pre-199031 (38.27)18.7374
1990's10 (12.35)18.2507
2000's11 (13.58)29.6817
2010's17 (20.99)24.3611
2020's12 (14.81)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.87 (24.57)
Research Supply Index4.51 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (4.44%)6.00%
Case Studies1 (1.11%)4.05%
Observational0 (0.00%)0.25%
Other85 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]